Serial antiarrhythmic therapy: Role of amiodarone in prevention of atrial fibrillation recurrence - A lesson from the HOT CAFE polish study

Cardiology

Volumn 104, Issue 1, 2005, Pages 35-44

  Kosior, Dariusz A ^a   Opolski, Grzegorz ^a   Wozakowska Kaplon, Beata ^b   Rabczenko, Daniel ^c  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Municipal Hospital   (Poland)

^c NATIONAL INSTITUTE OF HYGIENE   (Poland)

Author keywords

Amiodarone; Antiarrhythmic treatment; Atrial fibrillation; Cardioversion

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; DISOPYRAMIDE; PROPAFENONE; SOTALOL;

ABDOMINAL PAIN; ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ARTICLE; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DYSPEPSIA; ECZEMA; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART PROARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTHYROIDISM; LEUKEMIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SINUS RHYTHM; TORSADE DES POINTES; TREATMENT FAILURE; VOMITING; XEROSTOMIA;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE;

EID: 23944487166     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086053     Document Type: Article

References (36)

1. Pritchett ELC: Management of atrial fibrillation. N Engl J Med 1992;326:1264-1271.
2. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC: Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation 1990;82:1106-1116.
3. Flaker GC, Blackshear JL, McBride R, et al: Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992;20:527-532.
4. Reimond SC, Chalmers TC, Berlin JA, et al: Assessment of the efficacy and safety of antiarrhythmic therapy for chronic atrial fibrillation: Observation on the role of trial design and implications of drug-related mortality. Am Heart J 1992;124:924.
5. Friedman LP, Stevenson WG: Proarrhythmia. Am J Cardiol 1998;82:50N-58N.
6. Roy D, Talaijc M, Dorian P, et al: Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000;342:913-920.
7. Gosselink ATG, Crijns HJGM, Van Gelder IC, et al: Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA 1992;267:3289-3292.
8. Crijns HJGM, Van Gelder IC, Van Glist WH, et al: Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for persistent atrial fibrillation or flutter. Am J Cardiol 1991;68:335-341.
9. Opolski G, Torbicki A, Kosior DA, Szulc M, Wożakowska-Kapon B, Kołodziej P, Achremczyk P, Investigators of the Polish HOT CAFE Trial: Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: The Results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. Chest 2004;126:476-486.
10. Dreifus LS, Fisch C, Griffin JC, Gillette PC, Mason JW, Parsonnet V: Guidelines for implantation of cardiac pacemakers and antiarrhythmic devices: A report of the American College of Cardiology/American Heart Association task Force of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Pacemaker Implantation). Circulation 1991;84:455-467.
11. Laupacis A, Albers G, Dalen J, Dunn MI, Jacobson AK: Antithrombotic therapy in atrial fibrillation. Chest 1995;108:352-359.
12. Stanton MS, Prystowsky EN, Fineberg NS, et al: Arrhythmogenic drugs: A study of 506 patients treated for ventricular tachycardia or fibrillation. J Am Coll Cardiol 1989;14:200-215.
13. Opolski G, Stanislawska J, Górecki A, et al: Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current electrical cardioversion. Clin Cardiol 1997;20: 337-340.
14. Bramah NS: Amiodarone: The expanding antiarrhythmic role and how to follow a patient on chronic therapy. Clin Cardiol 1997;20:608-618.
15. Stafford RS, Robson DC, Misra B, et al: Rate control and sinus rhythm maintenance in atrial fibrillation: National trends in medication use, 1980-1996. Arch Intern Med 1998:158:2144-2148.
16. Van Gelder IC, Crijns HJGM, Tieleman RG, et al: Chronic atrial fibrillation. Success of serial electrical cardioversion therapy and safety of oral anticoagulation. Arch Intern Med 1996;156:2585-2592.
17. Brodsky MA, Allen BJ, Walker CJ, Casey TP, Luchet CR, Henry WL: Amiodarone for maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation in the setting of a dilated left atrium. Am J Cardiol 1987;60:572-575,
18. Gold RL, Haffajee CI, Charos K, Sloan K, Baker K, Baker S, Alpert JS: Amiodarone for refractory atrial fibrillation. Am J Cardiol 1986;57:124-127.
19. Middlekauff HR, Wiener J, Stevenson WG: Low-dose amiodarone for atrial fibrillation. Am J Cardiol 1993;72:75F-81F.
20. Horowitz LN, Spielman SN, Greenspan AM, Mintz GS, Morganroth J, Brown R, Brady PM, Kay HR: Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy. J Am Coll Cardiol 1985;6:1402-1406.
21. Sagrista-Sauleda J, Permanyer-Miralda G, Soler-Soler J: Electrical cardioversion after amiodarone administration. Am Heart J 1992;267:1536-1542.
22. Chun SA, Sager PT, Stevenson WG, Nademanee K, Middlekauff HR, Singh BN: Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. Am J Cardiol 1995;76:47-50.
23. Maintenance of sinus rhythm in patients with atrial fibrillation. An AFFIRM substudy of the first antiarrhythmic drug. JACC 2003;42:20-29.
24. Juul-Moller S, Edvardsson N, Ahlberg NR: Sotalol versus quinidine for the maintenance of sinus rhythm after direct-current electrical cardioversion of atrial fibrillation. Circulation 1990;82:1932-1941.
25. Antman EM, Beamer AD, Cantillon C, et al: Therapy of refractory atrial fibrillation and atrial flutter: A staged care approach with new antiarrhythmic drugs. J Am Coll Cardiol 1990;15:698-707.
26. Martin A, Benbow LJ, Leach C, Bailey RJ: Comparison of amiodarone and disopyramide in the control of paroxysmal atrial fibrillation and flutter. Br J Clin Pract Suppl 1986;40:52-60.
27. Van Gelder IC, Crijns HJGM, Van Gilst WH, et al: Efficacy and safety of flecainid acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter. Am J Cardiol 1989;64:317-321.
28. Nacarelli GV, Dorian P, Hohnloser SH, et al: Prospective comparison of flecainid versus quinidine for treatment of paroxysmal atrial fibrillation or flutter. Am J Cardiol 1996;77:A53-A59.
29. Podrid PJ, Lown B: Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias. Am Heart J 1981;101:374-379.
30. Fogoros RN, Anderson KP, Winkle RA, Swerdlow CD, Mason JW: Amiodarone: Clinical efficacy and toxicity in 96 patients with recurrent drug-refractory arrhythmias. Circulation 1983;63:88-94.
31. Peter T, Hamer A, Mandel WJ, Weiss D: Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: Follow-up. Am Heart J 1983;106:943-950.
32. Reader EA, Podrid PJ, Lown B: Side effects and complications of amiodarone therapy. Am Heart J 1985;109:975-978.
33. Smith WM, Lubbe WF, Whitlock RM, Mercer J, Rutherford JD, Roche AH: Long-term tolerance of amiodarone treatment for cardiac arrhythmias. Am J Cardiol 1986;57:1288-1293.
34. Vorperian VR, Havighurst TC, Miller S, January CT: Adverse effects of low dose amiodarone: Meta-analysis, J Am Coll Cardiol 1997;30:791-798.
35. Mason JW: Amiodarone. N Engl J Med 1987;316:455-466.
36. Kosior D, Karpinski G, Wretowski D, Stolarz P, Stawicki S, Rabczenko D, Torbicki A, Opolski G: Sequential prophylactic antiarrhythmic therapy for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation one-year follow-up. Kardiol Pol 2002;56:368-374.